Read the Latest News

And the Committee heard from the American Association of Oral and Maxillofacial Surgeons

At the end of the NAM meeting, Dr. Gregory Ness, representing the American Association of Oral and Maxillofacial Surgeons (AAMOS) gave the following comments: “AAMOS welcomes the interest and support of the Academies, the NIH, NIDCR, FDA and The

What Allen Told the Committee

Allen Cowley addressed the second open-to-the-public meeting of the National Institute of Medicine's (NAM) Committee on Temporomandibular Disorders (TMD) held on March 28, 2019 in Washington, DC. No stranger to the world of TMD, Dr. Cowley is the hus

Some Thoughts on Depression

It is hardly surprising that the chronic pain and limitations in function that many long-time TMJ patients experience can be accompanied by a state of depression, a sense of exhaustion and hopelessness.

Upcoming NAM Public Webinars on TMD

The National Academy of Medicine's (NAM) Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment is hosting two public web conferences on Wednesday, June 19 and Wednesday, July 31.   Webinar 1: Pati

The NAM Committee Heard from Patients, Too

At the March 28, 2019 public meeting NAM committee members had a chance to hear from TMD patients who had submitted testimony for the record.

Funding Opportunities now available for the NIH Common Fund’s Acute to Chronic Pain Signatures program

  • Aug 29, 2018

The NIH Common Fund’s Acute to Chronic Pain Signatures program aims to understand the biological characteristics underlying the transition from acute to chronic pain and what makes some people susceptible and others resilient to the development of chronic pain. A2CPS is part of the NIH-wide HEAL (Helping to End Addiction Long-term) Initiative, an aggressive, trans-NIH effort to speed scientific solutions to stem the national opioid public health crisis. 

Summary:  The A2CPS program will collect data from: (1) patients with acute pain associated with a surgical procedure and (2) patients with acute pain from a musculoskeletal trauma such as a broken bone. Neuroimaging, high-throughput biomedical measurements, sensory testing, and psychosocial assessments collected periodically after the acute pain event will form a comprehensive data set to help predict which patients will develop long-lasting chronic pain. The goal of these studies is to identify individual patient features that together, will provide clinically meaningful, predictive “signatures” of transition or resilience to chronic pain.

The NIH is inviting applications for five funding opportunities: 

Applications are due October 24, 2018.

An informational webinar will be held on September 6th, 2018 from 2-4 PM, EST. 

Join us via WebEx using this link

Call-in toll number (US/Canada): 1-650-479-3208

Event number: 624 155 354

Event password: PainSig

For additional information about the A2CPS program, please visit https://commonfund.nih.gov/pain and contact:

Linda L. Porter, Ph.D.  (RFA-RM-18-033, RFA-RM-18-034, RFA-RM-18-035)

National Institute on Neurological Disorders and Stroke (NINDS)

Telephone: 301-435-7572

Email: porterl@ninds.nih.gov

John Satterlee, Ph.D.  (RFA-RM-18-031, RFA-RM-18-032)

National Institute on Drug Abuse (NIDA)

Telephone: 301-435-1020

Email:  satterleej@nida.nih.gov

The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers, and Offices.  

The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about the NIH and its programs, visit the NIH website.

TMJ Disorders

Comments:

Login or Register to add Comment